Molecular Pharmacology & Therapeutics Graduate Program
The Molecular Pharmacology and Therapeutics (MPaT) Graduate Program has conferred over 350 Doctor of Philosophy (PhD) and 75 Master of Science (MS) degrees in Pharmacology, with most graduates applying their training to successful careers in academic, medical, industry, government, and regulatory agency settings. Among our notable alumni is Dr. Louis Ignarro (PhD, 1966; advisor: Dr. Frederick E. Shideman), who received the 1998 Nobel Prize in Physiology or Medicine for his pioneering work showing that nitric oxide is the gaseous second messenger that promotes vasodilation, the process underlying the beneficial therapeutic efficacy of drugs like nitroglycerin and sildenafil (Viagra). The MPaT Graduate Program currently offers MS and PhD degree programs and participates in joint degree (MD/PhD and JD/PhD) programs offered in partnership with the University of Minnesota Medical School and Law School.
Beginning in fall semester 2024, students can expect to see minor adjustments to the MPaT curriculum. These include tuning course credits of existing classes with the aim of increasing elective options and the addition of a new class.
Contact
Director of Graduate Studies
Dr. Anna Lee
[email protected]
612-626-2859
3-136 Nils Hasselmo Hall
Associate Director of Graduate Studies
Dr. Steven Graves
[email protected]
612-624-7335
3-106 Nils Hasselmo Hall
Director of Master's Studies
Dr. Ezequiel Marron
[email protected]
612-626-8480
2-104 Nils Hasselmo Hall
Graduate Program Coordinator
Marie Lindloff, MS
[email protected]
612-626-1248
2-108 Nils Hasselmo Hall
Human Resources/Payroll
[email protected]